What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.11%
Annual Rate
CNY 0.04Paid annual
Payout Ratio
15.0%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
19.50BCNY
2.90B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
114.24x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
3.71BCNY
551.35M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
6.66%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.9830x
vs all stocks
Updated Aug 20, 2026
52-Week Change
21.44%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
19.50BCNY
2.90B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
20.86BCNY
3.10B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
114.24x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Forward P/E
63.90x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
5.70x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 5.25×.Updated Aug 20, 2026
Price to Book (MRQ)
6.15x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
5.62x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
68.61x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 88.73×.Updated Aug 20, 2026
Gross Margin
22.05%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Profit Margin
6.66%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
8.97%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
3.05%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
4.60%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
3.71BCNY
551.35M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
6.61CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
10.80%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
748.58MCNY
111.18M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
235.15MCNY
34.93M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
247.15MCNY
36.71M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
107.60%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
224.21MCNY
33.30M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
161.83MCNY
24.04M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.0380CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
0.11%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
15.04%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 11.52%.Updated Aug 20, 2026
Minority Interest (Equity)
103.14MCNYFY2025 · Dec 31, 2025
Revenue
3.47BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.76BCNYFY2025 · Dec 31, 2025
Gross Profit
706.26MCNYFY2025 · Dec 31, 2025
Operating Income
207.51MCNY
30.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
153.85MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-16.49MCNYFY2025 · Dec 31, 2025
Net Income
170.34MCNYFY2025 · Dec 31, 2025
EBIT
159.44MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
434.35MCNYFY2025 · Dec 31, 2025
Research & Development
386.96MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
52.27MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
24.36MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
10.02MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.59MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2882CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2882CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
561.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
561.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
170.34MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-8.51MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
149.28MCNYFY2025 · Dec 31, 2025
Free Cash Flow
38.04MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
978.22MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
170.34MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
33.25MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-30.61MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-23.70MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-111.23MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-111.23MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
410.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-200.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-35.73MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-146.98MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
27.29MCNYFY2025 · Dec 31, 2025
Shares Outstanding
561.60MSharesUpdated Aug 20, 2026
Float Shares
289.96MSharesUpdated Aug 20, 2026
% Held by Insiders
49.56%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
1.78%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
959.36MCNY
142.48M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.71CNYUpdated Aug 20, 2026
Total Debt (MRQ)
546.66MCNY
81.19M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.1541x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.69x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
6.13CNYUpdated Aug 20, 2026
Total Assets
5.31BCNY
788.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.68BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.79BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.63BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
332.09MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.46BCNYFY2025 · Dec 31, 2025
Cash
421.39MCNYFY2025 · Dec 31, 2025
Cash Equivalents
646.11MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.07BCNYFY2025 · Dec 31, 2025
Accounts Receivable
615.33MCNYFY2025 · Dec 31, 2025
Inventory
656.86MCNYFY2025 · Dec 31, 2025
Accounts Payable
666.85MCNYFY2025 · Dec 31, 2025
Short-term Debt
396.57MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
149.75MCNYFY2025 · Dec 31, 2025
Long-term Debt
162.30MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
561.60MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.89BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.52BCNY
522.45M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
23.54CNYUpdated Aug 20, 2026
52-Week High
59.44CNYUpdated Aug 20, 2026
52-Week Change
21.44%
vs all stocks
Updated Aug 20, 2026
Beta
0.9830x
vs all stocks
Updated Aug 20, 2026
50-Day MA
41.36CNYUpdated Aug 20, 2026
200-Day MA
33.80CNYUpdated Aug 20, 2026
Avg 10-Day Volume
19.54MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
22.08MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.3300CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.